TMEM100 exhibited a clear inhibition of metastasis and proliferation in lung cancer, prostate cancer (PC), hepatocellular carcinoma (HCC) and gastric cancer (GC), and is correlated with the prognostic outcomes of above malignancies (5–11). Here, TMEM100 is linked to lung cancer.